Previous Close | 68.53 |
Open | 68.25 |
Bid | 68.52 x 1300 |
Ask | 68.59 x 300 |
Day's Range | 68.16 - 68.62 |
52 Week Range | 60.47 - 76.56 |
Volume | |
Avg. Volume | 6,318,930 |
Market Cap | 212.566B |
Beta (5Y Monthly) | 0.19 |
PE Ratio (TTM) | 35.90 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 1.45 (2.12%) |
Ex-Dividend Date | Feb 22, 2024 |
1y Target Est | N/A |
The FDA approves AstraZeneca's (AZN) Fasenra as an add-on maintenance treatment for patients with severe asthma aged six to 11 years.
J&J (JNJ) is set to buy Shockwave Medical (SWAV). FDA approves AstraZeneca's (AZN) Enhertu for metastatic HER2-positive solid tumors.
Astrazeneca (AZN) closed the most recent trading day at $69.45, moving +1.97% from the previous trading session.